Mired in the quagmire of uncertainty: The "catch-22" of embryonic stem cell research

Stem Cells and Development

Volumn 15, Issue 4, 2006, Pages 492-496

  Rao, Mahendra S ^a,b  

^a INVITROGEN CORPORATION   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EMBRYO; EMBRYONIC STEM CELL; ETHICS; FOOD AND DRUG ADMINISTRATION; GOVERNMENT; HUMAN; HUMAN CELL; MEDICAL RESEARCH; MORALITY; PLURIPOTENT STEM CELL; POLICY; PRIORITY JOURNAL; REVIEW; UNITED STATES;

ADULT; BIOTECHNOLOGY; CELL LINE; EMBRYO; HUMANS; PATENTS; PUBLIC POLICY; RESEARCH; STEM CELLS; UNCERTAINTY; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 33750686000     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2006.15.492     Document Type: Review

References (2)

1. English, D. (2001). Government funding of stem cell research: Did the President go far enough? J Hemato Stem Cell Res 10(5):581-582. Note: J Hemato Stem Cell Res was renamed Stem Cells and Development on Feb 1, 2005; it is the same journal.
2. U.S. Patent 5,843,780 for primate embryonic stem (pES) cells.